Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Mark W. Ball, Michael A. Gorin, Gunes Guner, Phillip M. Pierorazio, George Netto, Channing J. Paller, Hans J. Hammers, Luis A. Diaz, Mohamad E. Allaf

Research output: Contribution to journalArticle

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)e515-e520
JournalClinical Genitourinary Cancer
Volume14
Issue number5
DOIs
StatePublished - Oct 1 2016

Keywords

  • Biomarker
  • Cell-free DNA
  • Kidney cancer
  • Next-generation sequencing
  • Treatment response

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Ball, M. W., Gorin, M. A., Guner, G., Pierorazio, P. M., Netto, G., Paller, C. J., Hammers, H. J., Diaz, L. A., & Allaf, M. E. (2016). Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study. Clinical Genitourinary Cancer, 14(5), e515-e520. https://doi.org/10.1016/j.clgc.2016.03.019